tirzepatide off label GLP-1 medications are not approved by the Food and Drug Administration to treat polyendocrine metabolic ovarian syndrome (PMOS), the condition renamed from polycystic ovary syndrome in 2026. Because the use is off-label This is the most personal

Contact your pharmacy to request a new prescription fill

When providers and patients read a warning on a drug label, it feels true even if current evidence tells a different story

Stimulation of Metabolism of Rat Brown Adipose Tissue by Addition of Lipolytic Hormones In Vitro

12 pounds (lb) more than participants on the GLP-1 medication (semaglutide) 29 lb more than participants on insulin degludec 27 lb more than participants on insulin glargine Mounjaro stimulates insulin production, helping to improve insulin resistance

Improved Cardiovascular Health Many people who are dependent on Adderall experience high blood pressure and a rapid heartbeat

Detoxifying the body and removing harmful toxins